Mr Robert Ellis

BSc, BHlthSc (Hons)

MD/PhD Candidate

About me

Robert Ellis is an MD and PhD candidate at the University of Queensland.

Projects

Publications

 

Publications

Shen K, Vesey DA, Ellis RJ, Del Vecchio SJ, Cho Y, Teixeira-Pinto A, McGuckin MA, Johnson DW, Gobe GC. GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma. PloS ONE. 2019; 14(1): e0210246.

Ng KL, Ellis RJ, Samaratunga H, Morais C, Gobe GC, Wood ST. Utility of cytokeratin 7, S100A1 and caveolin 1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Transl Androl Urol. 2018. In Press. doi: 10.21037/tau.2018.11.02.

Ellis RJ, Kalma B, Del Vecchio SJ, Aliano DN, Ng KL, Dimeski G, Ma L, Guard D, Bertram JF, Morais C, Oliver K, Wood ST, Gobe GC, Francis RS. Chronic kidney cortical damage is associated with baseline kidney function and albuminuria in patients managed with radical nephrectomy for kidney tumours. Pathology. 2019; 51(1): 32-38.

Del Vecchio SJ, Owens EP, Ellis RJ. Kidney cancer biobanking: considerations for a single institutional biorepository. Transl Androl Urol. 2018. In Press. doi: 10.21037/tau.2018.10.15.

Ellis RJ. Chronic kidney disease after nephrectomy: a clinically-significant entity? Transl Androl Urol. 2018. In Press. doi: 10.21037/tau.2018.10.13.

Ellis RJ, Edey DP, Del Vecchio SJ, McStea M, Campbell SB, Hawley CM, Johnson DW, Morais C, Jordan SJ, Francis RS, Wood ST, Gobe GC; Cancer Alliance Queensland. End-stage kidney disease following surgical management of kidney cancer. Clin J Am Soc Nephrol. 2018; 13(11): 1641-8.

Del Vecchio SJ, Ellis RJ. Cabozantinib for the management of metastatic clear cell renal cell carcinoma. J Kidney Cancer VHL. 2018; 5(4): 1-5.

Ellis RJ, Del Vecchio SJ, Kalma B, Ng KL, Morais C, Francis RS, Gobe GC, Ferris R, Wood ST. Association between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumours. Int Urol Nephrol. 2018; 50(7): 1211-1217.

Ahn T, Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Hawley CM, Johnson DW, Marco DJT, McStea M, Neale RE, Pascoe EM, Wood ST, Jordan SJ; the IMPROVE Investigators. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis. J Surg Oncol. 2018; 117(7): 1597-1610.

Ellis RJ, Cho Y, Del Vecchio SJ, McStea M, Morais C, Coombes JS, Wood ST, Gobe GC, Francis RS. Outcome measures used to report kidney function in studies investigating surgical management of kidney tumours: a systematic review. Eur Urol Focus. 2018. In Press. doi: 10.1016/j.euf.2018.04.012.

Ellis RJ, Small DM, Ng KL, Vesey DA, Vitetta L, Francis RS, Gobe GC, Morais C. Indoxyl sulfate induces apoptosis and hypertrophy in human kidney proximal tubular cells. Toxicol Pathol. 2018; 46(4): 449-459.

Ellis RJ, Del Vecchio SJ, Ng KL, Owens EP, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. The Correlates of Kidney Dysfunction - Tumour Nephrectomy Database (CKD-TUNED) Study: protocol for a prospective observational study. Asian Pac J Cancer Prev. 2017; 18(12): 3281-3285.

Ellis RJ, Del Vecchio SJ, Ng KL, Dimeski G, Pascoe EM, Hawley CM, Johnson DW, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the CKD-TUNED study. Transl Androl Urol. 2017;6(5):899-909.

Ellis RJ, Joshi A, Ng KL, Francis RS, Gobe GC, Wood ST. Optimising assessment of kidney function when managing localised renal masses. Med J Aust. 2017;207(3):127-133.

Del Vecchio SJ, Ellis R, Gallagher K, Ng KL, Ma L, Strutton G, Wood S. A rare case of solitary kidney metastasis following primary laryngeal squamous cell carcinoma. J Kidney Cancer VHL. 2017;4(2):6-9.

Ellis RJ, Ng KL, Samaratunga H, Del Vecchio SJ, Wood ST, Gobe GC. Multifocal primary neoplasms in kidney allografts: evaluation of two cases. J Kidney Cancer VHL. 2016;3(2):14-22.

Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C. Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology. 2016; 21(3): 170-7.

Abstracts

Ellis R, Edey D, Del Vecchio S, McStea M, Hawley C, Johnson D, Vesey D, Morais C, Jordan S, Francis R, Wood S, Gobe G. End-stage kidney disease following surgical management of kidney cancer in Queensland. Nephrology. 2018; 23(S3): 24.

Del Vecchio S, Urquhart A, Krause L, Ellis R, Ng K, Samaratunga H, Gustafson S, Galloway G, Gobe G, Wood S, Mountford C. MR spectroscopy distinguishes histologically-diagnosed kidney tissue. Eur Urol Suppl. 2018; 17(2): e416.

Ahn T, Ellis R, Joshi A, Jordan S, Wood S. Utilization of nephrectomy in those with the greatest renal function decline post-surgery for small renal tumours based on RENAL nephrometry scores and co-morbidities: retrospective cohort study. BJU Int. 2018; 121(S1): 73.

Del Vecchio S, Ellis R, Urquhart A, Galloway G, Gobe G, Mountford C, Wood S. MR spectroscopy provides distinction between malignant clear cell renal cancers and indolent subtypes. Eur Urol Suppl. 2017; 16(9): e2611.

Del Vecchio S, Ellis R, Ng K, Gobe G, Wood S. Pre-operative eGFR and post-operative length of hospitalisation in tumour nephrectomy patients. Nephrology. 2017;22(S3):68.

Kalma B, Ellis RJ, Vitetta L, Wood ST, Gobe GC. Pilot study: urinary indoxyl sulphate as a predictor of postoperative kidney function following radical tumour nephrectomy. Nephrology. 2017;22(S3):43.

Ellis RJ, Del Vecchio SJ, Ng KL, Pascoe EM, Hawley CM, Johnson DW, Dimeski G, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. Elevated serum creatinine and acute kidney injury following radical tumour nephrectomy. Nephrology. 2017;22(S3):37.

Del Vecchio S, Urquhart A, Ellis R, Galloway G, Ng KL, Gobe G, Mountford C, Wood S. Signatures of kidney cancer identified by correlated spectroscopy. Asia Pac J Clin Oncol. 2017; 13(S1): 30.

Tiang K, Del Vecchio S, Ellis R, Ng KL, Gobe G, Wood S. Unique presentations of hybrid oncocytic/chromophobe RCC in a single tertiary hospital. BJU Int. 2017;119(S2):116.

Del Vecchio S, Urquhart A, Ng K, Ellis R, Galloway G, Mountford C, Wood S, Gobe G. Role of metabolic biomarkers using peak volume analysis in magnetic resonance spectroscopy for diagnosis of renal cell carcinoma. BJU Int. 2017;119(S2):71-2.

Vitetta L, Chien T, Ellis R, Morais C, Gobe G. Nephrotoxic effects of cisdiamminedichloroplatinium II (cisplatin) can be ameliorated using coenzyme Q10 (CoQ10). J World Mitochondria Soc. 2016;2(2). doi: 10.18143/JWMS_v2i2_1968.

Ellis RJ, Del Vecchio SJ, Ng KL, Vesey DA, Francis RS, Wood ST, Gobe GC. Kidney function following radical tumour nephrectomy. A comparison of functional outcomes by pre-operative CKD stage . Nephrology. 2016;21(S2):212.

Del Vecchio SJ, Ng KL, Ellis RJ, Samaratunga H, Wood ST, Gobe GC. Expression of S100 calcium binding protein A1 (S100A1) aids in the differentiation of renal cell carcinoma versus normal kidney tissue. Nephrology. 2016;21(S2):221.

Ellis RJ, Del Vecchio SJ, Park MG, Ng KL, Morais C, Francis RS, Gobe GC, Wood ST. Renal cell carcinoma: Analysis of clinical and demographic characteristics in a contemporary Australian cohort of 157 nephrectomy patients. Int J Urol. 2016; 23(S1): 56.

Ng KL, Ellis RJ, Del Vecchio SJ, Oh S, Small DM, Samaratunga H, Gobe GC, Wood ST. Immunohistochemical expression of kidney injury molecule-1 aids in the differentiation of chromophobe renal cell carcinoma and renal oncocytoma in an Australian cohort . Int J Urol. 2016;23(S1):129.

Ellis RJ, Ng KL, Gobe GC, Francis RS, Morais C, Wood ST. Renal cell carcinoma in kidney transplant recipients: a series of eight cases. BJU Int. 2015;116(S4):14-5.

Ellis RJ, Small DM, Ng KL, Vesey DA, Vitetta, L, Francis R, Morais C, Gobe GC. Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells. Nephrology. 2015;20(S3):25.

Research fields

Nephrology, Urology, Medicine